Cannabis use is common among individuals with HIV/AIDS. Its medical use for HIV symptom management continues to gain acceptance and recent changes to state laws have made it increasingly easier for HIV-seropositive (HIV+) individuals to obtain cannabis. Although cannabis has therapeutic potential, its use is also known to cause neurocognitive deficits. This is of particular concern to individuals with HIV, who are already vulnerable to such impairments. Indeed, a substantial amount of research shows that various substances of abuse often compound HIV-associated neurocognitive deficits. Yet, despite its widespread use, the effects of cannabis in this population have been relatively unexplored. Little is known regarding the type and extent of neurocognitive impairments that cannabis use may confer to HIV+ individuals, their impact on important functional behaviors (e.g., medication management), or the underlying mechanisms. The proposed project will address these issues by first characterizing rigorously how cannabis use and HIV relate to neuropsychological functioning in a large cohort of 400 community-dwelling adults, stratified by HIV-serostatus and cannabis use.
The second aim examines how cannabis use may adversely affect important functional """"""""real-world"""""""" behaviors of HIV+ individuals.
The final aim tests a theory-driven model that includes several mechanisms through which cannabis use may directly and indirectly influence neurocognitive functioning among HIV+ individuals. This model is based on strong preclinical evidence showing both immunosuppressive and anti-inflammatory effects of cannabinoids. Structural equation modeling will be used to test any direct effects that cannabis has on neurocognition, as well as any indirect effects that may be driven by its immunosupressive properties. The model will simultaneously examine if anti-inflammatory effects from cannabis are serving to mitigate neurocognitive deficits among those with HIV. The results of this proposal will yield a more complete understanding of how cannabis use influences neurocognition among HIV+ individuals. Our findings have the potential to improve the health and quality of life of HIV+ individuals, further neuroAIDS research, and inform healthcare decisions and policies regarding use of cannabis among individuals with HIV/AIDS.
This study will help us understand if cannabis use affects the neurocognitive functioning of HIV+ individuals and whether it impairs their ability to conduct important daily activities (e.g., managing medications and finances). It will also reveal if the effects of cannabis use on immune functioning and inflammatory processes are possible underlying mechanisms for its neurocognitive effects. The new information provided by our study has the potential to improve the health of individuals living with HIV/AIDS and may help policy makers and healthcare providers in deciding the role of cannabis in HIV/AIDS patient care.
|Vidot, Denise C; Lerner, Brenda; Gonzalez, Raul (2017) Cannabis Use, Medication Management and Adherence Among Persons Living with HIV. AIDS Behav 21:2005-2013|
|Ross, J Megan; Graziano, Paulo; Pacheco-Colón, Ileana et al. (2016) Decision-Making Does not Moderate the Association between Cannabis Use and Body Mass Index among Adolescent Cannabis Users. J Int Neuropsychol Soc 22:944-949|
|Ross, J Megan; Duperrouzel, Jacqueline; Vega, Melanie et al. (2016) The Neuropsychology of Risky Sexual Behavior. J Int Neuropsychol Soc 22:586-94|
|Ross, J Megan; Coxe, Stefany; Schuster, Randi M et al. (2015) The moderating effects of cannabis use and decision making on the relationship between conduct disorder and risky sexual behavior. J Clin Exp Neuropsychol 37:303-15|
|Gonzalez, Raul; Schuster, Randi M; Mermelstein, Robin M et al. (2015) The role of decision-making in cannabis-related problems among young adults. Drug Alcohol Depend 154:214-21|
|Crane, Natania A; Schuster, Randi Melissa; Mermelstein, Robin J et al. (2015) Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. J Clin Exp Neuropsychol 37:389-401|
|Schuster, Randi M; Crane, Natania A; Mermelstein, Robin et al. (2015) Tobacco may mask poorer episodic memory among young adult cannabis users. Neuropsychology 29:759-66|
|Crane, Natania A; Schuster, Randi Melissa; Fusar-Poli, Paolo et al. (2013) Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 23:117-37|
|Crane, Natania A; Schuster, Randi Melissa; Gonzalez, Raul (2013) Preliminary evidence for a sex-specific relationship between amount of cannabis use and neurocognitive performance in young adult cannabis users. J Int Neuropsychol Soc 19:1009-15|
|Gonzalez, Raul; Swanson, James M (2012) Long-term effects of adolescent-onset and persistent use of cannabis. Proc Natl Acad Sci U S A 109:15970-1|